Director at Vital Farms (VITL) receives 10,436-share RSU grant

Rhea-AI Filing Summary

Flanagan Glenda J reported acquisition or exercise transactions in this Form 4 filing.

Vital Farms, Inc. director Glenda J. Flanagan received a grant of 10,436 shares of common stock in the form of restricted stock units at no cash cost. These RSUs vest on the earlier of June 10, 2027 or the day before the company’s next annual meeting of stockholders, as long as she remains in continuous service.

After this compensation award, Flanagan holds a total of 47,934 shares of Vital Farms common stock directly, including the new RSU grant.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Flanagan Glenda J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,436	$0.00	--

Holdings After Transaction: Common Stock — 47,934 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 10,436 shares Grant price per share: $0.0000 per share Post-transaction holdings: 47,934 shares +1 more

4 metrics

RSU grant size 10,436 shares Restricted stock unit award to director Glenda J. Flanagan

Grant price per share $0.0000 per share Equity compensation, no cash paid for RSUs

Post-transaction holdings 47,934 shares Total Vital Farms common stock held directly after award

RSU vesting date June 10, 2027 Vests earlier of this date or day before next annual meeting

Key Terms

restricted stock unit ("RSU"), continuous service, annual meeting of stockholders, Grant, award, or other acquisition

4 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award."

continuous service financial

"subject to the Reporting Person's continuous service with the Issuer"

annual meeting of stockholders financial

"the day before the Issuer's next annual meeting of stockholders"

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 04:55 PM Accepted by SEC EDGAR 06/12/2026 - 04:55 PM Learn about SEC filing dates

FAQ

What insider transaction did Vital Farms (VITL) report for Glenda J. Flanagan?

Vital Farms reported that director Glenda J. Flanagan received a grant of 10,436 restricted stock units. These RSUs represent common stock awarded as equity compensation rather than an open-market purchase, and they were issued at no cash cost per share.

How many Vital Farms (VITL) shares does Glenda J. Flanagan hold after this Form 4?

After the reported award, Glenda J. Flanagan holds 47,934 shares of Vital Farms common stock directly. This total includes the newly granted 10,436 restricted stock units that will convert into shares as they vest over time, subject to service conditions.

When do Glenda J. Flanagan’s 10,436 Vital Farms RSUs vest?

The 10,436 restricted stock units vest on the earlier of June 10, 2027 or the day before Vital Farms’ next annual meeting of stockholders. Vesting requires Flanagan’s continuous service with the company through the applicable vesting date under the award terms.

Was Glenda J. Flanagan’s Vital Farms RSU grant an open-market stock purchase?

No. The filing classifies the transaction as a grant or award acquisition at a price of $0.0000 per share. It is equity compensation in the form of restricted stock units, not an open-market purchase of Vital Farms common stock on an exchange.

What does the Form 4 transaction code "A" mean for Vital Farms (VITL)?

The transaction code “A” on the Form 4 indicates a grant, award, or other acquisition of securities. In this case, it reflects Vital Farms granting 10,436 restricted stock units to director Glenda J. Flanagan as part of her compensation, rather than a market trade.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flanagan Glenda J

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE A100

(Street)

AUSTIN TEXAS 78704

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		10,436(1)	A	$0	47,934	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of (1) June 10, 2027 and (2) the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

	/s/ Francis Cullo, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)